QADRATTA Trademark

Trademark Overview

On Monday, June 4, 2018, a trademark application was filed for QADRATTA with the United States Patent and Trademark Office. The USPTO has given the QADRATTA trademark a serial number of 87947697. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 31, 2022. This trademark is owned by Noven Therapeutics, LLC. The QADRATTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of disorders of the central nervous system
qadratta

General Information

Serial Number87947697
Word MarkQADRATTA
Filing DateMonday, June 4, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of disorders of the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 11, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNoven Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33186
Party NameNoven Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33186

Trademark Events

Event DateEvent Description
Monday, January 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 10, 2021ASSIGNED TO EXAMINER
Thursday, June 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021EXTENSION 5 GRANTED
Thursday, June 10, 2021EXTENSION 5 FILED
Wednesday, June 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 10, 2021TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 4, 2020EXTENSION 4 GRANTED
Friday, December 4, 2020EXTENSION 4 FILED
Friday, December 4, 2020TEAS EXTENSION RECEIVED
Saturday, May 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 7, 2020EXTENSION 3 GRANTED
Thursday, May 7, 2020EXTENSION 3 FILED
Thursday, May 7, 2020TEAS EXTENSION RECEIVED
Monday, February 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 11, 2019EXTENSION 2 GRANTED
Wednesday, December 11, 2019EXTENSION 2 FILED
Wednesday, December 11, 2019TEAS EXTENSION RECEIVED
Friday, June 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2019EXTENSION 1 GRANTED
Wednesday, June 19, 2019EXTENSION 1 FILED
Wednesday, June 19, 2019TEAS EXTENSION RECEIVED
Tuesday, December 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 21, 2018ASSIGNED TO EXAMINER
Monday, June 11, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 7, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

qadratta nervous system central disorders preparations treatment pharmaceutical